---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-25-000158"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:25:22.144015+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q3 revenue $700M (-4% YoY); GAAP loss $10.78/sh on $701M impairment; Adj EPS $0.80

## Summary
- Total revenue $700M, down 4% YoY; non-respiratory revenue up 5% as reported, 6% constant currency ex-Donor Screening.
- GAAP net loss $733M includes $701M non-cash goodwill impairment; GAAP diluted EPS loss $10.78; adjusted diluted EPS $0.80.
- Adjusted EBITDA $177M, margin 25%, up 180 bps YoY driven by cost-savings initiatives.
- FY2025 guidance narrowed: revenue $2.68-$2.74B, adjusted EBITDA $585-$605M, adjusted diluted EPS $2.00-$2.15.
- Completed debt refinancing to improve financial flexibility with reduced amortization; terms not detailed.

## SEC filing metadata
- accession: 0001906324-25-000158
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632425000158/0001906324-25-000158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632425000158/qdel-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-25-000158
- JSON: https://secwatch.observer/filing/0001906324-25-000158.json
- Plain text: https://secwatch.observer/filing/0001906324-25-000158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.